In the Media

The liposome drug delivery devices market, currently valued at $3.64 billion, is expected to hit $5.30 billion by 2025 (10% CAGR). The growth is fueled by several factors, including economic growth and increased healthcare expenditure in emerging markets, an expanding elderly population needing advanced healthcare, and an increased number of research and innovation-driven pharmaceuticals

La start-up zurichoise s’est vu décerner, ce mardi, le statut de médicament orphelin pour son traitement phare VS-01, en cours de développement.

The spread of the sedentary Western lifestyle has fueled a global boom in liver disease. Traditionally caused by alcoholism and hepatitis, rising cases of diabetes and obesity across the world are responsible for a surge in fatty liver disease and liver cirrhosis, also known as end-stage liver disease.

Very positive coverage of our team, our lead product, and our first-in-man study currently enrolling patients at Goethe University Clinic Frankfurt.

We are proud to serve a role model and encourage all entrepreneurs to read the tips we present in the article. 

See the video interview

According to the Pioneers Asia jury, Versantis is addressing a serious problem that has previously been neglected, with a very strong team and expertise. 
Read the press coverage from Nikkei and from the Swiss Science and Technology Office in Tokyo. 

The Swiss pharmaceutical market magazine OTX WORLD published an interview of the laureate in French and German.

Good work the authors!

Versantis is featured in the CTI Invest® publication as a start-up on the way to success!

Vincent Forster (Versantis CEO) presented Versantis' innovative detoxification technology during a TED talk at TEDxHamburg. 

Vincent Forster and Jean-Christophe Leroux
Science Translational Medicine 7(229):p.290ps14

In this perspective article, we critically review the recent progresses in antidotal medicine which are rising to the challenge of the growing overdose epidemic. In the US, more than 2.5 million people are subjected to drug overdose which is the most common form of deliberate self-harm and accidental death!

"We want to save lives from drug overdoses" Article from Startwerk.ch 

"Versantis, using liposomes technology to detoxification" Article from LaBiotech.fr

Nice article about Versantis in the Handelszeitung!

Western Switzerland magazine Bilan published its yearly selection of promising startups looking for investors. Versantis is among them!

Check out the media release and related news. 

Versantis is among the winners of the >>venture>> Business Idea Award!

 This is a major achievement for the project and a great recognition from the medical community. BBC interview by The Naked Scientist broadcast.
ETH-News | Science Daily| Interpharma

**Great press coverage from Biotech Finance**

Versantis is among the winners of the >>venture>> Business Idea Award!